A new $6 billion manufacturing facility owned by Eli Lilly and Company is now coming to Huntsville. The commitment reportedly represents the largest initial investment in Alabama's history and will create approximately 3,450 manufacturing and construction jobs on-site.
According to the multinational pharmaceutical corporation, the Huntsville location will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1, orforglipron.
"Huntsville's track record of science and innovation, supported by advanced manufacturing expertise and a skilled workforce, makes Alabama an ideal location for Lilly to expand domestic manufacturing capacity for next‑generation medicines," said David A. Ricks, Lilly chair and CEO. "Today's investment continues the onshoring of active pharmaceutical ingredient (API) production, strengthening supply chain resilience and reliable access to medicines for patients in the U.S."
We’ve announced plans to build our third new U.S. manufacturing site this year in Huntsville, Alabama. See the details of the $6 billion facility, which will bring an expected 3,450 jobs: https://t.co/bvMEvTjZJ7 #WeAreLilly pic.twitter.com/lybhI8ljDI
— Eli Lilly and Company (@EliLillyandCo) December 9, 2025
Governor Kay Ivey praised Lilly's decision to open a facility in Huntsville, noting its historical significance to Alabama.
"Huntsville and our entire state have a proven legacy of innovation, and there is no better home for Lilly than right here in Alabama. Our roots in the biosciences industry run deep, and Alabama's contributions to this burgeoning sector continue," said Ivey. "We are proud to welcome Lilly's new U.S. manufacturing facility, which we are thrilled is the largest initial investment in our state's history."
"No doubt, Alabamians will help Lilly do things that have never been done before, and we will ensure this great company achieves their mission of improving the health and well-being of people all around the country and globe," added Ivey.
U.S. Rep. Dale Strong (R-Huntsville) called Lilly's commitment "huge news for Huntsville and American manufacturing."
Huge news for Huntsville and American manufacturing. Eli Lilly’s $6B investment, the largest in Alabama history, shows how President Trump’s leadership is driving major U.S. investment. Huntsville is a great place for the bioscience industry, and this project proves it. https://t.co/xBW8cFiNgC
— Dale W. Strong (@RepDaleStrong) December 9, 2025
U.S. Sen. Katie Britt (R-Montgomery) said the move from Lilly "underscores President Donald Trump's leadership" in driving American manufacturing to new heights.
Tremendous news for Alabama! Lilly’s $6 billion investment in Huntsville is the largest in our great state’s history.
— Senator Katie Boyd Britt (@SenKatieBritt) December 9, 2025
This transformational investment underscores @POTUS’s leadership in driving major domestic investments to revitalize and unleash American manufacturing dominance… https://t.co/qIj86W39UT
U.S. Sen. Tommy Tuberville (R-Auburn) wrote that Huntsville is unquestionably the right place for the facility, given the city's reputation for "cutting-edge technology and state-of-the-art facilities."
Glad to see more jobs coming to North Alabama.
— Coach Tommy Tuberville (@SenTuberville) December 9, 2025
Huntsville has proven time and time again to be the best home for cutting-edge technology and state-of-the-art facilities. Looking forward to seeing Alabama continue to lead the way in AMERICAN MANUFACTURING.https://t.co/dwDZPqakR6
Construction on the facility is expected to begin in 2026, with completion set for 2032.
To connect with the author of this story or to comment, email [email protected].
Don't miss out! Subscribe to our newsletter and get our top stories every day.